Sex‐Specific Genetic Architecture of ALS : Evidence of a Female Protective Effect?
Annals of Neurology · 2026
DOI: 10.1002/ana.78172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Maurizio Grassano und 20 weiteren Autor:innen. Beteiligte Einrichtung: Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Sex Characteristics. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Amyotrophic lateral sclerosis (ALS) shows sex differences in incidence and age of onset, yet the underlying biological mechanisms remain poorly understood.
Methods
We investigated sex‐specific genetic architecture in an Italian ALS cohort with whole‐genome sequencing (1,333 ALS cases, 755 controls). We performed a sex‐stratified burden analysis of rare variants in ALS‐associated genes and compared the proportions of male and female ALS patients carrying pathogenic or rare damaging variants. Key findings were replicated in the AnswerALS cohort ( n = 723). Gene‐specific sex ratios and familial history for C9ORF72 , SOD1 , and TARDBP were examined in an expanded dataset of 2,301 Italian ALS patients.
Results
Sex‐stratified burden testing revealed that rare variants in ALS genes were enriched in female cases versus controls (odds ratio [OR] 5.47, 95% confidence interval [CI] 1.60–34.29) but not in male cases. Female ALS patients more frequently carried rare damaging variants compared to males (23.2% vs 18.3%; OR 1.38, 95% CI 1.05–1.81), a finding that was replicated in the AnswerALS cohort (18.9% vs 12.4%; OR 1.58, 95% CI 1.10–2.26). Gene‐level analyses of TARDBP carriers revealed a male predominance (2.1:1), yet a higher rate of familial history among females (40.4% vs 24.5%; OR 2.13, 95% CI 1.03–4.39).
Interpretation
Females with ALS exhibited a higher overall burden of rare damaging variants, suggesting sex‐related differences in genetic liability. Gene‐level analyses indicate that the influence of sex varies across ALS genes, particularly TARDBP . These findings help explain epidemiological patterns and have implications for the identification of sex‐linked protective mechanisms. ANN NEUROL 2026
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy.
- Neurology Unit 1U, "City of Health and Science" University Hospital, Turin, Italy.
- Institute of Neurology, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.
- Institute of Cognitive Sciences and Technologies, National Council of Research, Rome, Italy.
ORCID-Profile: Maurizio Grassano, Antonio Canosa, Rosario Vasta, Andrea Calvo, Adriano Chiò
Zitieren
APA
Grassano, M., Palumbo, F., Mora, G., Gallone, S., De Marco, G., Merulla, I., Paolantonio, C., Maccabeo, A., Canosa, A., Manera, U., Vasta, R., Iazzolino, B., Testa, M., Fuda, G., Salamone, P., Marchese, G., Casale, F., Moglia, C., Calvo, A., …, & Chiò, A. (2026). Sex‐Specific Genetic Architecture of ALS : Evidence of a Female Protective Effect?. Annals of Neurology. https://doi.org/10.1002/ana.78172
Vancouver
Grassano M, Palumbo F, Mora G, Gallone S, De Marco G, Merulla I, et al. Sex‐Specific Genetic Architecture of ALS : Evidence of a Female Protective Effect?. Annals of Neurology. 2026. doi:10.1002/ana.78172
BibTeX
@article{Grassano2026,
author = {Grassano, Maurizio and Palumbo, Francesca and Mora, Gabriele and Gallone, Salvatore and De Marco, Giovanni and Merulla, Ilaria and Paolantonio, Claudia and Maccabeo, Alessandra and Canosa, Antonio and Manera, Umberto and Vasta, Rosario and Iazzolino, Barbara and Testa, Marcella and Fuda, Giuseppe and Salamone, Paolina and Marchese, Giulia and Casale, Federico and Moglia, Cristina and Calvo, Andrea and Borghero, Giuseppe and Chiò, Adriano},
title = {Sex‐Specific Genetic Architecture of ALS : Evidence of a Female Protective Effect?},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78172}
}
EUVIMED